<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        103-186-99
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1999
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        UROXIN 400MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        NORFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        400
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        41.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Norfloxacin the active ingredient contained in <strong>Uroxin </strong>belongs to a group of antibiotics called quinolones which work by killing bacteria that cause infections. This medicine is indicated for the treatment of bacterial infections of the urinary tract e. g. cystitis, pyelitis and chronic prostatitis</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take this medicine </strong></p><p>&bull; if you are allergic (hypersensitive) to norfloxacin, other quinolone antibiotics or any of the other ingredients of <strong>Uroxin </strong></p><p>&bull; if you are pregnant or think you could be pregnant</p><p>&bull; if you have had pain, inflammation or rupture of tendons after taking quinolone antibiotics (see &ldquo;Take special care with this medicine&rdquo; and &ldquo;4. Possible side effects&rdquo;)</p><p>&bull; if you have not reached puberty or are a teenager who is still growing Take special care with this medicine</p><p><strong>Take special care with this medicine</strong></p><p>&bull; if you have a history of convulsions (symptoms include body twitching, jerking limbs, fits), or a disorder that increases the risk of having convulsions</p><p>&bull; if you suffer from psychiatric disorders, hallucinations and/or confusion</p><p>&bull; if you suffer from a condition called myasthenia gravis (an auto-immune disease) which causes muscle weakness</p><p>&bull; if you or any member of your family suffers from a deficiency disorder where patients become anaemic after taking certain drugs (glucose-6-phosphate dehydrogenase, G-6-PD deficiency) (symptoms of anaemia include paleness and tiredness)</p><p><strong>Heart problems</strong></p><p>Caution should be taken when using this kind of medicine, if you were born with or have family history of prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes (see section Taking other medicines). Pain, inflammation or rupture of tendons, particularly around the ankles may occur with this class of antibiotics, especially if you are older or if you are taking corticosteroids at the same time. If you experience tendon pain or signs of inflammation of the Achilles tendon stop taking your medicine and contact your doctor and rest the affected limb. Providing you do not have a problem with your heart or kidneys, you should drink plenty of liquid whilst taking this medicine. This medicine may cause a problem with your kidneys called &ldquo;crystalluria&rdquo; which results in tiny crystals forming in the urine. These crystals cannot be seen by the naked eye. Drinking plenty of liquid can help prevent this occurring. You should avoid excessive sunlight while taking this medicine as the drug may make your skin more sensitive to sunlight or UV light. If you develop severe and persistent diarrhoea whilst you are taking your tablets or after stopping your tablets you should consult your doctor.</p><p><strong>Patients with kidney problems </strong></p><p>If you suffer from severe renal impairment your doctor may prescribe you a lower dosage of this medicine.</p><p><strong>Taking other medicines </strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p><strong>You must tell your doctor if you are taking other medicines that can alter your heart rhythm: </strong></p><p>Medicines that belong to the group of anti-arrhythmics (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), tricyclic antidepressants, some antimicrobials (that belong to the group of macrolides), some antipsychotics.</p><p><strong>There are some other medicines which may interfere with this medicine, particularly:</strong></p><p>&bull; nitrofurantoin, a medicine used in the treatment of infections</p><p>&bull; probenecid, a medicine used in the treatment of gout and gouty arthritis</p><p>&bull; theophylline, found in certain medicines used to treat asthma and some cough/decongestant medicines</p><p>&bull; caffeine-containing medications (e.g. certain analgesics)</p><p>&bull; ciclosporin, a medicine used to dampen the body&rsquo;s immune response</p><p>&bull; warfarin or other blood-thinning medicines</p><p>&bull; multivitamins or products containing iron, magnesium, calcium or zinc</p><p>&bull; antacids or sucralfate</p><p>&bull; fenbufen, a medicine for rheumatism</p><p>&bull; oral contraceptives: this medicine may decrease the effect of oral contraceptives</p><p><strong>Taking Uroxin with food and drink </strong></p><p>Take your medicine at least one hour before or two hours after a meal or milk products such as yoghurt. Multivitamins, products containing iron or zinc, antacids or sucralfate should not be taken at the same time as this medicine. This medicine should be taken either 2 hours before or at least 4 hours after such products.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant, planning a family or breast-feeding, tell your doctor before taking this medicine, as it is not recommended for use under these conditions.</p><p><strong>Driving and using machines </strong></p><p>Your reactivity may be altered so that your ability to drive or operate machinery is impaired, especially at the start of treatment, on increasing the dosage or when switching medication and in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take your medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong><u>Dosage </u></strong></p><p>The usual dose in <strong>adults</strong> is 1 tablet of <strong>Uroxin </strong>(400 mg) twice daily.</p><p><strong>Dosage in patients with kidney problems </strong></p><p>If you suffer from severe renal impairment, your doctor may adjust your dosage. The recommended dose is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1 tablet of <strong>Uroxin </strong>(400 mg) once daily. Swallow the tablets with a glass of water at least one hour before or two hours after a meal or drink of milk.</p><p>Preferably the tablets should be taken in the morning and evening.</p><p>&nbsp;If you only take a single daily dose, always take this at the same time of day.</p><p>The duration of treatment depends on the type and severity of infection. For women with acute, uncomplicated inflammation of the bladder, the usual duration of treatment is a 3 day course of this medicine with the recommended dose.</p><p>In the treatment of urinary tract infections, adults will generally need to use this medicine for 7-10 days.</p><p>In chronic inflammation of the prostate the usual duration of treatment is 4 weeks.</p><p>The symptoms of urinary tract infection, such as a burning sensation experienced during passing water, pain, and fever, will generally disappear within 1-2 days. However, the treatment course with this medicine should be continued for up to 12 weeks in chronic relapsing urinary tract infections. If the infection is adequately controlled within the first 4 weeks of treatment, the dose may be reduced to 400mg of <strong>Uroxin </strong>(1 tablet) daily.</p><p><strong>If you take more Uroxin than you should </strong></p><p>If you have taken a double dose, you only need to contact your doctor if side effects occur. Continue taking your medicine regularly as prescribed. If you have taken more than a double dose by mistake, contact your doctor immediately.</p><p><strong>If you forget to take Uroxin </strong></p><p>Do not take a double dose to make up for a forgotten tablet, just carry on with the next one as normal.</p><p><strong>If you stop taking Uroxin </strong></p><p>&nbsp;It is important that you complete the course of treatment, even if you begin to feel better after a few days. If you stop taking this medicine too soon, your symptoms may return.</p><p><strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>If you experience any of the following rare symptoms or side effects, stop the treatment and seek medical advice immediately: </strong></p><p>&bull; An allergic reaction soon after you start taking the tablets - including: swelling of the face, lips, tongue and/or throat (with difficulty in breathing or swallowing), itching, nettle rash, and severe skin reactions causing blisters and bleeding (exfoliative dermatitis, toxic epidermal necrolysis, Stevens-Johnson syndrome). Allergic reactions can, very rarely, be life-threatening.</p><p>&bull; Inflammation of the membrane that lines a joint capsule and very rarely rupture of the tendon e.g. Achilles tendon. If you experience tendon pain or signs of inflammation of the Achilles tendon, stop taking this medicine, seek medical advice <strong>immediately</strong> and rest the affected limb (see &ldquo;Take special care with this medicine&rdquo;).</p><p>Inflammation of the liver with jaundice (yellowing of the skin or whites of the eyes) commonly occurs. Stop treatment and contact your doctor if you experience signs and symptoms of liver problems such as loss of appetite, jaundice, dark urine, itching or sensitivity to pressure in the abdominal cavity.</p><p>If you develop the rare side effect of severe and persistent diarrhoea whilst you are taking your tablets or after stopping your tablets you should consult your doctor.</p><p>In rare cases seizures occur. If fits occur, stop taking this medicine.</p><p><strong>Other possible side effects:</strong></p><p>&nbsp;<strong>Common</strong> (less than 1 in 10, but more than 1 in 100 persons treated)</p><p>&bull; Breakdown of the muscle tissue with muscle pain, weakness (rhabdomyolysis)</p><p>&nbsp;<strong>Uncommon</strong> (less than 1 in 100, but more than 1 in 1,000 persons treated)</p><p>&bull; Reduced number of white blood cells &ldquo;leucocytes&ldquo; [leucopenia] or &ldquo;neutrophiles&rdquo; [neutropenia], increased number of certain white blood cells &ldquo;eosinophiles&rdquo; [eosinophilia], which may cause sore throat and mouth, increased frequency of infections</p><p>&bull; Reduced number of blood platelets [thrombocytopenia], reduced volume of the red blood cells in the blood [hematocrit], reduced blood clotting ability, which may cause prolonged bleeding after injury</p><p>&bull; Headache, dizziness and drowsiness</p><p>&bull; Abdominal pain and cramps, heartburn, diarrhoea and sickness</p><p>&bull; Increased liver enzymes</p><p>&bull; Rash</p><p>&bull; Effects on the kidney which cause pain and discomfort when passing water (crystalluria)</p><p><strong>Rare </strong>(less than 1 in 1,000, but more than 1 in 10,000 persons treated)<strong> </strong></p><p>&bull; Skin reactions to sunlight (see &ldquo;Take special care with this medicine&rdquo;)</p><p>&bull; Anaemia (paleness and tiredness), sometimes associated with Glucose-6-phosphate-dehydrogenase deficiency, due to a red cell loss</p><p>&bull; Tiredness, changes of mood, a tingling sensation, sleeplessness, sleep disturbances, depression, feeling of anxiety, restlessness, irritability, exaggerated sense of well being, disorientation, hallucinations, confusion</p><p>&bull; Disorders of the nerves including Guillain-Barr&eacute; syndrome, psychic disturbances and psychotic reactions</p><p>&bull; Worsening of a condition called myasthenia gravis which causes muscle weakness (see &ldquo;Take special care with this medicine&rdquo;)</p><p>&bull; Visual disturbance, increased production of tears</p><p>&bull; Ringing in the ears</p><p>&bull; Bleeding into the skin with inflammation of blood vessels</p><p>&bull; Vomiting (being sick), loss of appetite, inflammation of the pancreas (symptoms include abdominal pain, fever, being sick)</p><p>&bull; Muscle and/or joint pains, inflammation of the joints</p><p>&bull; Inflammation of the kidneys (symptoms may include blood in the urine, decreased urine)</p><p>&bull; Vaginal thrush (itching, soreness or burning of the vagina)</p><p><strong>Not known</strong> (cannot be estimated from the available data)</p><p><strong>Heart problems </strong></p><p>&bull; Abnormal fast heart rhythm, life-threatening irregular heart rhythm, alteration of the heart rhythm (called &lsquo;prolongation of QT interval&rsquo;, seen on ECG, electrical activity of the heart)</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p><p><strong><u>&nbsp;</u></strong></p><p><strong><u>To report any side effect(s)</u></strong><strong><u>: </u></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax: </strong>+966-11-205-7662</p><p><strong>Call NPC at </strong>+966-11-2038222</p><p><strong>Exts: </strong>2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone: </strong>8002490000</p><p><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>Website: </strong>www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not take <strong>Uroxin </strong>after the expiry date which is stated on the carton and on the blister.</p><p>-&nbsp; Store below 30&deg;C, in a dry place, protected from light.</p><p>-&nbsp; Do not take <strong>Uroxin </strong>if you notice any visible sign of deterioration.</p><p>-&nbsp; &nbsp;Medicines shoul<em>d </em>not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is norfloxacin. Each film-coated tablet contains 400mg of norfloxacin.</p><p>The other ingredients: primojel, croscarmellose sodium, microcrystalline cellulose, povidone, magnesium stearate, hypromellose, and titanium dioxide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Uroxin film-coated tablets are available in pack of 14 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
01/12/2015

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي <strong>يروكسين</strong> على المادة الفعالة نورفلوكساسين وهي مضاداً حيوياً من مجموعة الكوينولون التي تعمل عن طريق القضاء على البكتيريا المسببة في حدوث العدوى. يستخدم هذا الدواء لعلاج حالات العدوى البكتيرية في الجهاز البولي على سبيل المثال التهاب المثانة والتهاب حوض الكلية والتهاب البروستاتا المزمن.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم تناول هذا الدواء في الحالات التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحساسية (فرط الحساسية) تجاه نورفلوكساسين، المضادات الحيوية من مجموعة الكوينولون الأخرى أو أياً من المواد الأخرى في <strong>يروكسين</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت حاملاً أو تعتقدين بأنك حامل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا عانيت سابقاً من ألم، التهاب أو تمزق في الأربطة بعد تناول إحدى أدوية مضادات الحيوية من مجموعة الكوينولون &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(انظر &quot;<strong> </strong>تحذيرات<strong> </strong>خاصة قبل هذا الدواء&quot; و &quot;قسم 4 : التأثيرات الجانبية المحتمل حدوثها&quot;)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا لم تكن تصل إلى سن البلوغ أو أنت في مرحلة المراهقة حيث مازلت في مرحلة البلوغ، فيجب عليك توخي الحذر مع تناول هذا الدواء.</p><p dir="RTL"><strong>تحذيرات خاصة قبل تناول هذا الدواء</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا لديك تاريخ مرضي مع حدوث التشنجات (تتضمن الأعراض على ارتعاش الجسم، ارتعاش الأطراف، نوبات صرع)، أو اضطرابات التي تزيد من خطر حدوث التنشجات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطرابات نفسية، هلوسة و/أو ارتباك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حالة مرضية تعرف باسم وهن العضلي الوبيلي (اضطراب المناعة الذاتية) التي تسبب الضعف في العضلات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; إذا كنت تعاني أو أحد أفراد عائلتك يعاني من اضطرابات النقص التي تؤدي إلى حدوث فقر الدم بعد تناول أدوية معينة &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(عوزِ سداسي فوسفات الجلوكوز النازع للهيدروجين) (تتضمن أعراض فقر الدم على شحوب لون البشرة والشعور بالتعب)</p><p dir="RTL"><strong>مشاكل في القلب</strong></p><p dir="RTL">يجب توخي الحذر مع تناول بمثل هذا الدواء، إذا كنت تعاني من الصغر أو لديك تاريخ عائلي مع إطالة في فترة كيو تي (يتم الكشف عنها عن طريق تخطيط كهربائية القلب)، اختلال توازن الأملاح في الدم (وبصفة خاصة انخفاض مستوى البوتاسيوم أو المغنيسيوم في الدم)، تباطؤ معدل ضربات القلب (يعرف باسم &quot;بطء القلب&quot;)، ضعف في القلب (فشل القلب)، لديك تاريخ مرضي مع حدوث أزمات قلبية (احتشاء عضلة القلب)، إذا كنت أنثى أو من فئة كبار السن أو كنت تتناول أدوية أخرى التي تؤدي إلى حدوث تغيرات غير طبيعية في تخطيط كربائية القلب (انظر تناول الأدوية الأخرى).</p><p dir="RTL">من الممكن أن يحدث ألم، التهاب أو تمزق في الأوتار، وخاصة حول منطقة الكاحلين عند تناول إحدى المضادات الحيوية من مجموعة الكوينولون، وبصفة خاصة إذا كنت من فئة كبار السن أو إذا كنت تتناول تلك المضادات الحيوية بالتزامن مع كورتيكوستيرويدات.&nbsp; يرجى منك التوقف عن تناول الدواء الخاص بك والتواصل مع طبيبك المعالج وإراحة الطرف المصاب إذا عانيت مسبقاً من آلام في الوتر أو علامات التي تدل على حدوث التهاب الوتر العقبي.</p><p dir="RTL">من أجل عدم المعاناة من مشاكل في القلب أو الكلى، يجب عليك شرب كمية كافية من السوائل أثناء تناول هذا الدواء. قد يؤدي هذا الدواء إلى حدوث مشكلة في الكلى تعرف باسم &quot;بيلة البلورات&quot; الناجمة عن تكون بلوات صغيرة في البول. لا يمكن رؤية تلك البلورات بالعين المجردة. من الممكن شرب الكمية الكافية من السوائل المساعدة على منع حدوث تلك المشكلة.</p><p dir="RTL">يجب عليك تجنب التعرض المفرط لأشعة الشمس أثناء تناول هذا الدواء حيث قد يصبح جلد أكثر حساسية لأشعة الشمس أو أشعة فوق البنفسجية. يرجى منك التواصل مع طبيبك المعالج إذا عانيت من إسهال شديد ومستمر أثناء تناول هذا الدواء أو بعد التوقف عن تناوله.</p><p dir="RTL"><strong>المرضى الذين يعانون من مشاكل في الكلى</strong></p><p dir="RTL">إذا كنت تعاني من قصور كلوي شديد فقد يصف لك طبيبك المعالج جرعة بمقدار أقل من هذا الدواء.</p><p dir="RTL"><strong>تناول الأدوية الأخرى</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخراً أية أدوية أخرى، بما في ذلك الادوية التي تصرف بدون وصفة طبية.</p><p dir="RTL"><strong>يجب عليك إخبار طبيبك المعالج إذا كنت تتناول أدوية أخرى التي من الممكن أن تغير من نظم القلب:</strong></p><p dir="RTL">الأدوية التي تنتمي إلى مجموعة مضادات اضطراب نظم القلب (على سبيل المثال الكينيدين، هيدروكينون، ديسوبيراميد، أميودارون، سوتالول، دوفيتيليد، إيبوتيليد)، مضادات الاكتئاب ثلاثية الحلقات، وبعض مضادات الميكروبات (التي تنتمي إلى مجموعة ماكروليدات)، وبعض مضادات الذهان.</p><p dir="RTL"><strong>قد يؤدي تناول بعض الأدوية الأخرى بالتزامن مع هذا الدواء إلى حدوث تفاعلات دوائية، وبصفة خاصة:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; نتروفورانتوين، يستخدم في علاج العدوى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; بروبينسيد، يستخدم في علاج النقرس والتهاب المفاصل النقرسي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ثيوفيلين، يتواجد في أدوية معينة التي تستخدم في علاج الربو وبعض أدوية التي تستخدم لعلاج السعال والاحتقان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الأدوية التي تحتوي على مادة الكافيين (على سبيل مثال مسكنات الألم معينة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; سيكلوسبورين، دواء يستخدم لتثبيط استجابة جهاز المناعي في الجسم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الوارفارين أو غيرها من الأدوية &nbsp;التي تستخدم لمنع تجلط الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الفيتامينات المتعددة أو الأدوية التي تحتوي على الحديد والمغنيسيوم والكالسيوم أو الزنك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; مضادات الحموضة أو سكرالفات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فينبوفين، &nbsp;دواء يستخدم لعلاج الروماتزم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; وسائل منع الحمل الفموية: قد يقلل هذا الدواء من تأثير وسائل منع الحمل الفموية</p><p dir="RTL"><strong>تناول </strong><strong>يروكسين مع الطعام والشراب</strong></p><p dir="RTL">يجب عليك تناول الدواء الخاص بك بمدة لا تقل عن ساعة واحدة قبل أو ساعتين بعد تناول وجبة الطعام أو المنتجات اللبنية على سبيل المثال اللبن. يجب عدم تناول الفيتامينات المتعددة والمستحضرات التي تحتوي على الحديد أو الزنك، مضادات الحموضة أو سكرالفات بالتزامن مع هذا الدواء. يجب تناول هذا الدواء أما ساعتين قبل أو مدة لا تقل عن 4 ساعات بعد تناول تلك المستحضرات.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج قبل تناول هذا الدواء، إذا كنت حاملاً، تخططين بإنجاب طفلاً أو ترضعين طفلك رضاعة طبيعية، حيث لا يوصى بتناول هذا الدواء أثناء تلك الفترات.</p><p dir="RTL"><strong>القيادة واستخدام الآلات </strong></p><p dir="RTL">قد يؤثر هذا الدواء على قدرتك على القيادة أو تشغيل الآلات، وبصفة خاصة في بداية العلاج، عند زيادة مقدار الجرعة أو عند تغير الدواء وعند تناول هذا الدواء بالتزامن مع الكحول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احرص دائماً على تناول هذا الدواء بدقة وفقاً لتعليمات طبيبك المعالج. يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه ما لم تكن متأكداً من كيفية تناول هذا الدواء.</p><p dir="RTL"><strong><u>الجرعة</u></strong></p><p dir="RTL">يبلغ مقدار الجرعة الاعتيادية <strong>للبالغين</strong> قرصاً واحداً من <strong>يروكسين </strong>(400 ملغم) مرتين يومياً.</p><p dir="RTL"><strong>الجرعة للمرضى الذين يعانون من مشاكل في الكلى</strong></p><p dir="RTL">إذا كنت تعاني من قصور كلوي شديد، فقد يقوم طبيبك المعالج بتعديل الجرعة الخاصة بك. يبلغ المقدار الجرعة الموصى بها قرصاً واحداً من <strong>يروكسين </strong>(400 ملغم) مرة واحدة يومياً. يجب ابتلاع القرص مع شرب كوباً من الماء قبل ساعة على الاقل أو بعد مرور ساعتين من تناول وجبة الطعام أو شرب الحليب.</p><p dir="RTL">يفضل تناول الأقراص في الصباح والمساء.</p><p dir="RTL">يجب عليك تناول الدواء الخاص بك في نفس الوقت يومياً، إذا كنت تتناول جرعة واحدة يومياً.</p><p dir="RTL">تعتمد مدة العلاج على نوع وشدة العدوى. تبلغ مدة العلاج الاعتيادية 3 أيام لتناول الجرعة الموصى بها من هذا الدواء من قبل نساء اللواتي يعانين من التهاب حاد غير مصحوب بمضاعفات في المثانة.</p><p dir="RTL">بصورة عامة يبلغ مدة العلاج للبالغين لعلاج عدوى جهاز البولي من 7 إلى 10 أيام</p><p dir="RTL">يبلغ مدة العلاج 4 أسابيع لعلاج التهاب البروستاتا المزمن.</p><p dir="RTL">تتضمن أعراض عدوى الجهاز البولي على احساس بالحرق أثناء التبول، ألم وحرارة، وعامة سوف تختفي هذه الأعراض في غضون 1-2 يوم. على الرغم من ذلك، يجب الاستمرار بتناول هذا الدواء لمدة تصل إلى 12 أسبوع لعلاج عدوى الجهاز البولي المزمن الانتكاسي. في حال تحسن حالة العدوى في غضون 4 أسابيع الأولى من العلاج، فقد يتم تقليل مقدار جرعة إلى 400 ملغم من <strong>يروكسين </strong>(قرصاً واحداً) يومياً.</p><p dir="RTL"><strong>إذا تناول يروكسين بجرعة أكبر مما يجب&nbsp; </strong></p><p dir="RTL">يرجى منك التواصل مع طبيبك المعالج فقط عند المعاناة من تأثيرات جانبية في حال تناولت جرعة مضاعفة. يجب عليك الاستمرار بتناول الدواء الخاص بك بشكل دوري كما هما موصى به. يرجى منك التواصل مع طبيبك المعالج على الفور، إذا تناولت جرعة بمقدار أكبر من جرعة مضاعفة على سبيل الخطأ.</p><p dir="RTL"><strong>إذا سهوت عن تناول يروكسين </strong></p><p dir="RTL">يجب عليك عدم تناول جرعة مضاعفة لتعويض عن الجرعة التي قد سهوت عنها، يجب عليك تناول الجرعة التالية كالمعتاد.</p><p dir="RTL"><strong>إذا توقفت عن تناول يروكسين</strong></p><p dir="RTL">من المهم استكمال الجدول الدوري للعلاج، وحتى وإن كنت تشعر بتحسن بعد مرور بضعة أيام من بدء العلاج. إذا توقفت عن تناول هذا الدواء في وقت مبكر جداً، فقد تعاود ظهور الأعراض لديك.</p><p dir="RTL"><strong>يرجى منك </strong><strong>استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء<strong> </strong>إلى حدوث تأثيرات جانبية، ولكنها لا تحدث لكل شخص.</p><p dir="RTL"><strong>يرجى منك التوقف عن تناول هذا الدواء واطلب نصيحة طبية على الفور، إذا عانيت من أية أعراض أو التأثيرات الجانبية&nbsp; النادرة التالية:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; أية تفاعلات تحسسية في وقت مبكر من تناول هذا الدواء- تتضمن على: تورم الوجه، الشفتين، اللسان و/أو الحلق (مع صعوبة في التنفس أو البلع)، حكة، طفح القراص وتفاعلات جلدية شديدة مسببة في ظهور كدمات وتقرحات وحدوث نزيف (التهاب الجلد المتقشر، انحلال البشرة السمي التنخري، ومتلازمة ستيفنز جونسون). من الممكن أن تكون التفاعلات التحسسية التي تحدث بصورة نادرة جداً مهددة للحياة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التهاب الغشاء الذي يبطن المحفظة المفصلية وحدوث تمزق &nbsp;في الوتر بصورة نادر جداً على سبيل المثال وتر العرقوب. يرجى منك التوقف عن تناول هذا الدواء، اطلب المشورة الطبية <strong>على الفور</strong> وعليك إراحة الطرف المصاب، إذا عانيت من ألم في الوتر أو علامات التي تدل على حدوث التهاب في وتر العرقوب (انظر &quot;تحذيرات خاصة مع هذا الدواء&quot;).</p><p dir="RTL">يحدث التهاب الكبد مصحوباً باليرقان (اصفرار الجلد أو بياض العينين) بصورة شائعة. يرجى منك التوقف عن تناول هذا الدواء والتواصل مع طبيبك المعالج إذا عانيت من علامات وأعراض تدل على حدوث مشاكل في الكبد على سبيل المثال فقدان الشهية، يرقان، بول داكن اللون، حكة أو ضغط في تجويف البطن.</p><p dir="RTL">يرجى منك التواصل مع طبيبك المعالج إذا عانيت من التأثيرات الجانبية&nbsp; النادرة على سبيل المثال إسهال شديد ومستمر أثناء فترة تناول هذا الدواء أو بعد التوقف عن تناوله.</p><p dir="RTL">لقد حدثت نوبات صرع في حالات نادرة. يرجى منك التوقف عن تناول هذا الدواء في حال حدوث ذلك.</p><p dir="RTL"><strong>التأثيرات الجانبية الأخرى:</strong></p><p dir="RTL"><strong>الشائعة </strong>(تؤثر على أقل من شخص واحد من كل 10 أشخاص، ولكن أكثر من شخص واحد من كل 100 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تكسر الأنسجة العضلية مصحوباً بحدوث ألم وضعف في العضلات (انحلال الربيدات)</p><p dir="RTL"><strong>الغير شائعة </strong>(تؤثر على أقل من شخص واحد من كل 100 شخص، ولكن أكثر من شخص واحد من كل 1000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; انخفاض تعداد خلايا الدم البيضاء &quot;الخلايا المتعادلة&quot; (قلة الخلايا المتعادة)، زيادة أنواع معينة من خلايا الدم البيضاء &quot;الحمضات&quot; (فرط الحمضات)، الذي يؤدي إلى حدوث التهاب الحلق والفم، زيادة معدل حدوث العدوى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; انخفاض تعداد الصفائح الدموية، انخفاض حجم خلايا الدم الحمراء في الدم (هيماتوكريت)، انخفاض القدرة على&nbsp;تكوين جلطات الدم، الذي قد يؤدي إلى إطالة فترة النزيف بعد الإصابة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; صداع، دوخة ونعاس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; آلام وتقلصات غير طبيعية، حرقة المعدة، إسهال وتوعك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ارتفاع انزيمات الكبد</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; طفح جلدي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تأثيرات تؤثر على الكبد التي قد تؤدي إلى الشعور بالألم وبعدم الراحة عند التبول (بيلة البلورات)</p><p dir="RTL"><strong>ال</strong><strong>نادرة</strong> (تؤثر على أقل من شخص واحد من كل 1000 شخص، ولكن أكثر من شخص واحد من كل 10000 شخص)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تفاعلات جلدية تجاه أشعة الشمس (انظر &quot;عناية خاصة مع تناول هذا الدواء&quot;)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; فقر الدم (شحوب لون الجلد والشعور بالتعب)، و بعض الأحيان يكون مصاحباً بحدوث عوزِ سداسي فوسفات الجلوكوز النازع للهيدروجين الناتج عن انخفاض خلايا الدم الحمراء</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الشعور بالتعب، تغيرات في المزاج، الإحساس بتنميل، الشعور بالنعاس، اضطرابات في النوم، اكتئاب، الشعور بالقلق، أرق، تهيج، الشعور بالتحسن بصورة مفرطة، ارتباك، هلوسة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اضطرابات في الأعصاب بما في ذلك متلازمة غيلان باريه، اضطرابات نفسية وتفاعلات نفسية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تدهور حالة مرض الوهن العضلي الوبيلي الذي يسبب ضعف في العضلات (انظر &quot;عناية خاصة مع هذا الدواء&quot;)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; اضطرابات في البصر، زيادة إفراز الدموع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; طنين في الأذنين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حدوث نزيف تحت الجلد مصحوباً بحدوث التهاب في الأوعية الدموية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تقيؤ (الإعياء)، فقدان الشهية، التهاب البنكرياس (تتضمن الأعراض على ألم في المعدة، حمى، توعك).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; آلام في العضلات و/أو المفاصل، التهاب في المفاصل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; التهاب في الكلى (تتضمن الأعراض على ظهور دم في البول، قلة التبول)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; داء القلاع في المهبل (حكة، ألم وحرقة في المهبل)</p><p dir="RTL"><strong>الغير معروفة</strong> (لا يمكن تقدير معدل حدوثها من البيانات المتوفرة)</p><p dir="RTL"><strong>مشاكل في القلب</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; تسارع غير طبيعي في ضربات القلب، عدم انتظام ضربات القلب المهددة للحياة، تغيرات في نظم القلب (تعرف باسم &quot;إطالة في فترة كيو تي&quot; يكشف عنها عن طريق تخطيط كهربائية القلب)</p><p dir="RTL"><strong>في </strong><strong>حال زيادة حدة الأعراض الجانبية،</strong><strong> أو إذا لاحظت حدوث تأثيرات جانبية أخرى لم تذكر في هذه النشرة، يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية</u></strong><strong><u>:</u></strong></p><p dir="RTL"><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p dir="RTL"><strong>رقم الفاكس:</strong> 7662-205-11-966+</p><p dir="RTL"><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على:</strong> 2038222-11-966+</p><p dir="RTL"><strong>وصلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p dir="RTL">الهاتف المجاني: 8002490000</p><p dir="RTL"><strong>البريد الإلكتروني:</strong> npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>الموقع الإلكتروني:</strong> www.sfda.gov.sa/npc</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>يروكسين &nbsp;</strong>&nbsp;بعد تاريخ انتهاء الصلاحية المذكور على العبوة والأمبولة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة أقل من 30&deg;م، في مكان جاف، بعيداً عن الضوء.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم تناول <strong>يروكسين &nbsp;</strong>&nbsp;إذا لاحظت وجود علامات تلف واضحة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي نورفلوكساسين. يحتوي كل قرص مكسو على 400 ملغم من&nbsp; نورفلوكساسين.</p><p dir="RTL">المواد الأخرى: بريموجل، صوديوم كروس كارميلوز، بلورات سليلوز متناهية الصغر، بوفيدون، استيارات المغنيسيوم، هيبروميلوز وثنائي أكسيد التيتانيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر أقراص <strong>يروكسين </strong>المكسوة<strong> </strong>في عبوة تحتوي على 14 قرصاً.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
01/12/2015

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Uroxin 400mg Tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains: 

Item No. 	Material Name 	Scale (mg/Tablet)
		
	Active Ingredient: 	
1.		Norfloxacin 	400.000
		
	Inactive Ingredients: 	
1.		Sodium starch glycolate (Primojel)	25.000
2.		Crosscarmellose sodium (Ac-Di-Sol)	20.000
3.		Microcrystalline cellulose (Avicel PH 102)	69.000
4.		Polyvinyl pyrrolidone 	1.000
5.		Magnesium stearate 	5.000
6.		Ethanol Absolute *	q.s
		
	Coating Materials:	
1.		Hypromellose	7.000
2.		Titanium dioxide 	3.000
3.		Purified water* 	q.s 
4.		Alcohol (Ethanol 95%)*	q.s

* Evaporates during manufacturing process and does not appear in the final product.

For a full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-Coated Tablets
Description: white to off-white, oval shape, biconvex film-coated tablets 
Marking: Face one: Score-line
Face two: Plain

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Uroxin</strong><em> </em>is indicated for the treatment of the following bacterial infections caused by pathogens susceptible to norfloxacin: upper and lower complicated and uncomplicated, acute and chronic urinary tract infections, including cystitis, pyelitis, and chronic prostatitis.</p><p>Consideration should be given to official local guidance e.g. national recommendations regarding the appropriate use and prescription of antibacterial agents.</p><p>Susceptibility of the causative organism to the treatment should be tested (if possible), although therapy may be initiated before the results are available.</p><p>In case of suspected failure of therapy, microbiological investigation for possible bacterial resistance should be undertaken.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Dosage in adults</u></strong></p><p>Adults should take 1 film-coated tablet (400mg norfloxacin) twice daily.</p><p><strong><u>Dosage in elderly patients</u></strong></p><p>Elderly patients should also take 1 film-coated tablet (400mg norfloxacin) twice daily. Normally, dosage adjustment in this group of patients is not required if there is no significant renal impairment.</p><p><strong><em>Dosage in patients with impaired renal function</em></strong></p><p>For all these patients whose creatinine clearance is below 30ml/min x 1.73m2 and who do not require haemodialysis, the recommended dose is 1 film-coated tablet of <strong>Uroxin</strong><em> </em>(400mg norfloxacin) once daily. At this dosage, concentrations in appropriate body fluids and tissues exceed the MICs for most pathogens responsible for urinary tract infections and sensitive to norfloxacin.</p><p><strong>Uroxin</strong><em> </em>is contraindicated in children and growing adolescents (see also 4.3 &ldquo;Contraindications&rdquo;).</p><p><strong><em><u>Mode of administration</u></em></strong></p><p>&sect;&nbsp; The film-coated tablets should be swallowed with sufficient fluid (e.g. a glass of water) at least one hour before or two hours after a meal or ingestion of milk.</p><p>&sect;&nbsp; The film-coated tablets should preferably be taken in the morning and evening.</p><p>&sect;&nbsp; In the case of a single daily dose, this should always be taken at the same time of day.</p><p>&sect;&nbsp; In women with acute, uncomplicated inflammation of the bladder, a 3 day course of norfloxacin with the recommended dose has frequently proved sufficient.</p><p>&sect;&nbsp; In the treatment of urinary tract infections, adults will generally need to use norfloxacin for 7-10 days.</p><p>&sect;&nbsp; In case of chronic prostatitis good results were achieved by treatment with the recommended dose for 4 weeks.</p><p>&sect;&nbsp; The symptoms of urinary tract infection, such as a burning sensation experienced during micturation, pain, and fever, will generally disappear within 1-2 days. However, the treatment course with norfloxacin 400mg tablets<em> </em>should be continued up to 12 weeks in chronic relapsing urinary tract infections. If adequate suppression is obtained within the first 4 weeks of therapy, the dose may be reduced to 400mg norfloxacin (1 film-coated tablet) daily.</p><p>&sect;&nbsp; At present there are no clinical data available for treating patients for more than eight weeks.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	Hypersensitivity to norfloxacin, other chemotherapeutic agents belonging to the quinolone class or any of the excipients.
	Norfloxacin should not be used in pregnancy and lactation (see section 4.6).
	Norfloxacin is contraindicated in patients with a history of tendinitis and/or tendon rupture related to fluoroquinolone administration (see section 4.4 and
	4.8).
	Norfloxacin is contraindicated in prepubertal children and growing adolescents as there are insufficient findings on safety of use in these groups of subjects and, on the basis of results in animal studies, damage to articular cartilage in the immature organism cannot be totally excluded.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Hypersensitivity reactions</em></strong></p><p>Norfloxacin can cause serious, potentially fatal hypersensitivity reactions (anaphylactic and anaphylactoid reactions), occasionally following the initial dose (see section 4.8). Patients should be advised to discontinue treatment immediately if experiencing such reactions and contact their physician or an emergency physician, who will initiate appropriate emergency measures.</p><p><strong><em>Tendinitis and/or tendon rupture</em></strong></p><p>Norfloxacin should not be used in patients with a present or past injury, inflammation or rupture of the Achilles tendon (see 4.8).</p><p>Tendinitis and/or tendon rupture (particularly the Achilles tendon) may occur with quinolone antibiotics. Such reactions have been observed, particularly in older patients and in those treated concurrently with corticosteroids. On the appearance of tendon pain or signs of inflammation of the Achilles tendon, treatment with norfloxacin must be discontinued immediately and the patient treated accordingly.</p><p><strong><em>Use in patients with epilepsy and other CNS disorders</em></strong></p><p>Norfloxacin<em> </em>should only be used if there is an overwhelming clinical need in patients with known epilepsy or disorders which lower the seizure threshold. Convulsions have been reported in rare cases in patients receiving norfloxacin. Norfloxacin may lead to exacerbation and aggravation of the symptoms in patients with known or suspected psychiatric disorders, hallucinations and/or confusion.</p><p>In case of convulsive seizures, treatment with norfloxacin should be discontinued.</p><p><strong><em>Use in patients with myasthenia gravis</em></strong></p><p>Norfloxacin can exacerbate the symptoms of myasthenia gravis which may result in life threatening weakness of respiratory muscles. Adequate counter measures should be taken at any sign of respiratory distress.</p><p><strong><em>Use in renal impairment</em></strong></p><p>In patients with severe renal impairment, the risk/benefit ratio of using norfloxacin<em> </em>should be carefully weighed for the individual (see 4.2). The urinary concentration of norfloxacin may be reduced in patients with severely impaired renal function as norfloxacin is predominantly excreted via the kidneys.</p><p><strong><em>Crystalluria</em></strong></p><p>In case of prolonged treatment, the occurrence of crystalluria should be monitored. While crystalluria is not expected to occur under normal conditions with a dosage regimen of 400mg twice daily, as a precaution, the daily recommended dosage should not be exceeded and the intake of sufficient fluids should be guaranteed to ensure a proper state of hydration and adequate urinary output.</p><p><strong><em>Photosensitivity</em></strong></p><p>Photosensitivity reactions have been observed in patients who are exposed to excessive sunlight while receiving some substances of this drugs class.</p><p>Excessive sunlight and the use of sun beds should be avoided during treatment with norfloxacin. Therapy must be discontinued if photosensitivity occurs.</p><p><strong><em>G6PD-(Glucose-6-phosphate-dehydrogenase) deficiency</em></strong></p><p>In patients with latent or actual G6PD-(Glucose-6-phosphate-dehydrogenase) deficiency quinolone class haemolytic reactions are possible.</p><p><strong><em>Pseudomembranous colitis</em></strong></p><p>The occurrence of severe and persistent diarrhoea during or after therapy may be an evidence for very rarely observed pseudomembranous colitis. In such cases therapy must be stopped immediately and a suitable therapy (e.g. vancomycin, 4 x 250mg by oral route) has to be started. Drugs inhibiting peristalsis are contraindicated.</p><p><strong><em>Cholestatic hepatitis</em></strong></p><p>Cholestatic hepatitis is commonly reported with norfloxacin (see section 4.8)</p><p>Patients should be advised to stop treatment and contact their doctor if signs and symptoms of hepatic disease develop such as anorexia, jaundice, dark urine, pruritus or tender abdomen.</p><p><strong><em>Cardiac disorders</em></strong></p><p>Caution should be taken when using fluoroquinolones, including norfloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:</p><p>&sect; congenital long QT syndrome</p><p>&sect; concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics)</p><p>&sect; uncorrected electrolyte imbalance (e.g. hypokalaemia, hypomagnesaemia)</p><p>&sect; cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)</p><p>&sect; Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluroquinolones, including norfloxacin, in these populations.</p><p>(See section 4.2 Elderly, section 4.5, section 4.8, section 4.9).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In-vitro antagonism of nitrofurantoin. Concomitant administration of</p><p>nitrofurantoin and norfloxacin should therefore be avoided. <em>Probenecid </em>reduces urinary excretion of norfloxacin, but does not affect its serum concentration.</p><p>Norfloxacin inhibits CYP 1A2, which might lead to interactions with other drugs metabolised by this enzyme.</p><p>Elevated plasma levels of theophylline have been reported with concomitant theophylline and quinolone use. Isolated cases of theophylline-related side effects have also been reported in patients on concomitant therapy with norfloxacin and theophylline. Plasma levels of theophylline should therefore be monitored and the dosage adjusted as required.</p><p>The Metabolism of caffeine has been shown to be inhibited by quinolones and also by norfloxacin. This can result in delayed elimination and prolonged plasma half-life of caffeine. During treatment with norfloxacin the ingestion of caffeine-containing medications (<em>e.g. certain analgesics) </em>should therefore be avoided where possible.</p><p>Elevated serum levels of cyclosporin have been reported with concomitant use of norfloxacin. Cyclosporin serum concentrations should therefore be monitored and the dosage adjusted as appropriate.</p><p>Quinolones, including norfloxacin, may enhance the effects of the oral anticoagulant warfarin or its derivatives. If these medications are given concomitantly, the prothrombin time or other suitable coagulation parameters should be carefully monitored.</p><p>Miscellaneous compounds (preparations containing iron/antacids and products containing magnesium, aluminium, calcium or zinc): simultaneous administration of norfloxacin with multivitamin preparations containing calcium, preparations containing iron or zinc, antacids or sucralfate reduces the absorption of norfloxacin, leading to markedly decreased concentrations in serum and urine. Norfloxacin should therefore be taken either 2 hours before or at least 4 hours after such products. The restriction does not apply to H2- receptor antagonists.</p><p>Oral nutritional solutions and dairy products (milk or milk products such as yoghurt) reduce the absorption of norfloxacin. Norfloxacin should therefore be taken at least 1 hour before or 2 hours after such products.</p><p>On the basis of animal studies, concomitant administration of quinolones and fenbufen can cause seizures. Co-administration of quinolones and fenbufen should therefore be avoided.</p><p>Some antibiotics have been reported to decrease the effect of oral contraceptives possibly through interference with the bacterial hydrolysis of steroid conjugates in the gut and thereby reduced re-absorption of the steroid.</p><p><strong>Drugs known to prolong QT interval</strong></p><p>Norfloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and</p><p>III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics) (see section 4.4)</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em><u>Pregnancy</u></em></strong></p><p>Pregnant women and breast feeding mothers should not be prescribed <em>400 mg tablets </em>as there are insufficient findings on safety of use in these groups of<em> </em>subjects and, on the basis of results from animal studies, damage to articular<em> </em>cartilage in the immature organism cannot completely be excluded. Animal<em> </em>studies have not shown any evidence of teratogenic effects. Norfloxacin passes<em> </em>into umbilical blood and amniotic fluid.</p><p><strong><em><u>Lactation</u></em></strong></p><p>It is generally known that quinolones pass into mother&acute;s milk. In case of treatment of breast-feeding mothers with norfloxacin, breast feeding must be stopped.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Norfloxacin may alter a patient&acute;s reactivity so that the ability to drive, operate machinery or work without firm support is impaired, especially at the start of treatment, on increasing the dosage or when switching medication and in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; very common (&ge;1/10)</p><p>&sect; common (&ge;1/100 to &lt;1/10)</p><p>&sect; uncommon (&ge;1/1000 to &lt;1/100)</p><p>&sect; rare (&ge;1/10000 to &lt;1/1000)</p><p>&sect; very rare (&lt;1/10000)</p><p>&sect; not known (cannot be estimated from the available data)</p><p><strong><u>Blood and the lymphatic system disorders</u></strong></p><p><em>Uncommon</em>: Leucopenia, neutropenia, eosinophilia, thrombocytopenia, reduced hematocrit, prolongation of prothrombin time.</p><p><em>Rare</em>: Haemolytic anaemia, sometimes associated with Glucose-6 phosphate dehydrogenase deficiency.</p><p><strong><u>Immune system disorders</u></strong></p><p><em>Rare</em>: Anaphylactic/anaphylactoid reactions (see section 4.4).</p><p>Not known: Hypersensitivity</p><p><strong><u>Psychiatric disorders</u></strong></p><p><em>Rare</em>: Changes of mood, depression, feeling of anxiety, nervousness, irritability, euphoria, disorientation, hallucinations, confusion, psychic disturbances and psychotic reactions.</p><p><strong><u>Nervous system disorders</u></strong></p><p><em>Uncommon</em>: Headache, dizziness and drowsiness.</p><p><em>Rare</em>: Paresthesia, insomnia, sleep disturbances, polyneuropathy including Guillain-Barr&eacute; syndrome and seizures, and possible exacerbation of myasthenia gravis (see section 4.4).</p><p><strong><u>Eye disorders</u></strong></p><p><em>Rare</em>: Visual disturbance, increased lacrimation.</p><p><strong><u>Ear and labyrinth disorders</u></strong></p><p><em>Rare</em>: Tinnitus</p><p><strong><u>Cardiac disorders</u></strong></p><p><em>Not known</em>: Tachycardia, ventricular arrhythmia and torsades de pointes (reported predominantly in patients with risk factors for QT prolongation), ECG QT prolonged (see section 4.4 and 4.9).</p><p><strong><u>Vascular disorders</u></strong></p><p><em>Rare</em>: Petechiae and haemorrhagic bullae/papules with vasculitis.</p><p><strong><u>Gastrointestinal disorders</u></strong></p><p><em>Uncommon</em>: Abdominal pain and cramps, heartburn, diarrhoea and nausea.</p><p><em>Rare</em>: Vomiting, loss of appetite, pseudomembranous colitis (see section 4.4), pancreatitis.</p><p><strong><u>Hepatobiliary disorders</u></strong></p><p><em>Common</em>: Cholestatic hepatitis (see section 4.4), hepatitis.</p><p><em>Uncommon</em>: Elevation of ALT (SGOT), AST (SGPT) and alkaline phosphatase.</p><p>Not known: Jaundice</p><p><strong><u>Skin and subcutaneous tissue disorders</u></strong></p><p><em>Uncommon</em>: Rash</p><p><em>Rare</em>: Skin reactions, exfoliative dermatitis, toxic epidermal necrolysis (Lyell&acute;s syndrome), erythema multiforme (Stevens-Johnson syndrome), photosensitivity (see section 4.4), pruritus and urticaria, angiooedema.</p><p><strong><u>Musculoskeletal, connective tissue and bone disorders</u></strong></p><p><em>Common</em>: Rhabdomyolysis</p><p><em>Rare</em>: Tendinitis, tendosynovitis, (see section 4.4), muscle and/or joint pains, joint inflammation.</p><p>Very rare: Rupture of tendons (e.g. Achilles tendon) (see section 4.4).</p><p><strong><u>Renal and urinary disorders</u></strong></p><p><em>Uncommon</em>: Crystalluria</p><p><em>Rare</em>: Interstitial nephritis</p><p><strong><u>Reproductive system and breast disorders</u></strong></p><p><em>Rare</em>: Vaginal candidiasis</p><p><strong><u>General disorders and administration site conditions</u></strong></p><p><em>Rare</em>: Tiredness</p><p><strong><em><u>Note</u></em></strong></p><p>Photosensitivity has been observed in patients who, during ongoing therapy with quinolone-like medications, have been extensively exposed to sunlight or sunbeds (phototoxic reactions, photosensitisation with vesiculation, redness, swelling and discolouration.); (see section 4.4).</p><p>&nbsp;</p><p><strong><em><u>To report any side effect(s): </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation. In the event of acute overdosage, the stomach should be emptied by induced vomiting or by gastric lavage. The patient should be carefully observed and given symptomatic and supportive treatment as required.</p><p>Adequate hydration must be maintained to prevent crystalluria.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmaco-therapeutic group: </strong>Norfloxacin is a bactericidal antibiotic belonging to the group of<strong> </strong>fluoroquinolones.</p><p><strong>ATC Code: </strong>J01MA06</p><p><strong><u>Mode of action</u></strong></p><p>Norfloxacin inhibits bacterial deoxyribonucleic acid (DNA) synthesis by inhibition of bacterial topoisomerase II (gyrase) and topoisomerase IV.</p><p><strong><u>Relationship between pharmacokinetics and pharmacodynamics</u></strong></p><p>Efficacy is mainly dependent upon the Cmax (maximum serum concentration):MIC (minimum inhibitory concentration) ratio of the pathogen and the AUC (area under the curve): MIK ratio of the pathogen, respectively.</p><p><strong><u>Mechanism(s) of resistance</u></strong></p><p>Resistance to norfloxacin can derive from the following mechanisms:</p><p>&sect; Modified target structures: The main mechanism of resistance against norfloxacin and other fluoroquinolones consists in changes of topoisomerase II and IV as a result of mutation.</p><p>&sect; Other mechanisms of resistance lead to reduced concentration of fluoroquinolones at the site of action. Therefor liable are a reduced penetration into the bacterial cell due to reduced formation of porins or an increased efflux out of the cell via efflux pumps.</p><p>&sect; Transferable, plasmid-coded resistance was demonstrated in Escherichia coli and Klebsiella spp.</p><p>There is a partial or complete cross-resistance between norfloxacin and other fluoroquinolones.</p><p><strong><em><u>Breakpoints</u></em></strong></p><p>Testing of norfloxacin is performed by using the usual dilution series. The following minimum inhibitory concentrations were determined for sensitive and resistant micro-organisms:</p><p>EUCAST (European Committee on Antimicrobial Susceptibility Testing)</p><p>Breakpoints:</p><p><strong>Species sensitive resistant</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:546px"><tbody><tr><td style="vertical-align:top"><p><strong>Species </strong></p></td><td style="vertical-align:top"><p><strong>sensitive</strong></p></td><td style="vertical-align:top"><p><strong>resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacteriaceae</em></p></td><td style="vertical-align:top"><p>&le; 0,5mg/l</p></td><td style="vertical-align:top"><p>&gt; 1mg/l</p></td></tr><tr><td style="vertical-align:top"><p>Non-species related breakpoints*</p></td><td style="vertical-align:top"><p>&le; 0,5mg/l</p></td><td style="vertical-align:top"><p>&gt; 1mg/l</p></td></tr></tbody></table><p>* based mainly on serum pharmcokinetics</p><p><strong><u>Prevalence of acquired resistance</u></strong></p><p>The prevalence of resistance may vary geographically and with time for selected species. Data on the local resistance information are thus desirable, particularly in order to ensure adequate treatment of severe infections. If the local resistance situation puts the efficacy of norfloxacin in doubt, expert therapeutic advice should be sought. Particularly in cases of severe infection or unsuccessful therapy, a microbiological diagnosis with confirmation of the micro-organism and its sensitivity norfloxacin should be undertaken.</p><p>Prevalence of acquired resistance on the basis of data from the past 5 years from national resistance monitoring projects and studies</p><p><strong><u>Commonly susceptible species</u></strong></p><p><strong>Aerobic Gram-positive micro-organisms</strong></p><p><em>Staphylococcus saprophyticus</em>&deg;</p><p><strong>Aerobic Gram-negative micro-organisms</strong></p><p><em>Enterobacter aerogenes</em></p><p><em>Enterobacter cloacae</em></p><p><em>Proteus vulgaris</em></p><p><em>Salmonella enterica (enteritis salmonella)</em>&deg;</p><p><em>Serratia marcescens</em></p><p><strong>Species for which acquired resistance may be a</strong></p><p><strong>problem</strong></p><p><strong>Aerobic Gram-positive micro-organisms</strong></p><p><em>Enterococcus faecalis</em><strong>&sect;</strong></p><p><em>Staphylococcus aureus (methicillin-sensitive)</em></p><p><strong>Aerobic Gram-negative micro-organisms</strong></p><p><em>Campylobacter jejuni</em>$</p><p><em>Citrobacter freundii</em></p><p><em>Escherichia coli</em>&amp;</p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae</em></p><p><em>Morganella morganii</em></p><p><em>Neisseria gonorrhoeae</em></p><p><em>Proteus mirabilis</em></p><p><em>Pseudomonas aeruginosa</em></p><p><strong>Inherently resistant organisms</strong></p><p><strong>Aerobic Gram-positive micro-organisms</strong></p><p><em>Enterococcus faecium</em></p><p><em>Staphylococcus aureus (methicillin-resistant)</em></p><p><em>Streptococcus agalactiae</em></p><p><strong>Aerobic Gram-negative micro-organisms</strong></p><p><em>Stenotrophomonas maltophilia</em></p><p><strong>Anaerobic micro-organisms</strong></p><p><em>Clostridium difficile</em></p><p><strong>Other micro-organisms</strong></p><p><em>Chlamydia trachomatis</em></p><p>Mycoplasma hominis</p><p><em>Ureaplasma urealyticum</em></p><p>&deg;<em>At the time of publication of the table, no current data were available.</em></p><p><em>Sensitivity is assumed in the primary literature, standard works and therapy recommendations</em>.<em> </em></p><p><em>$Most isolates show natural intermediate susceptibility</em></p><p><em>&amp;Resistance rate in isolates of patients with uncomplicated cystitis is &lt;10 %, in others &gt;10%</em>.</p><p><em>&nbsp;</em></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Norfloxacin is rapidly absorbed after oral administration. In healthy volunteers, at least 30-40% of an oral dose is absorbed.</p><p>Serum concentrations of 1.5&mu;g/ml are obtained one hour after administration of a dose of 400mg.</p><p>The mean serum half-life is three to four hours and independent of the dose.</p><p>The half-life is doubled in patients with severe renal impairment (creatinine clearance 30ml/min).</p><p>Mean concentrations in body fluids and tissues which have been measured 1-4 hours after 2 doses of 400mg norfloxacin were within a range of 1.6-7.3&mu;g/ml.</p><p>Norfloxacin is excreted by the kidney and in the bile following partial metabolism.</p><p>Renal elimination occurs by glomerular filtration and tubular secretion, as is also apparent from the high renal clearance (approximately 275ml/min).</p><p>Norfloxacin is found in urine as the unchanged compound and in the form of 6 active metabolites with slight antibacterial efficacy. The non-metabolised form constitutes more than 70% of the total elimination. The bactericidal activity of norfloxacin is not influenced by the urinary pH. Concentrations of 2.5mg/l in human serum leads to binding to plasma proteins of nearly 13.8%.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>As with other quinolones, administration of norfloxacin led to arthropathy in immature animals. No similar pathology has been observed in adult animals.</p><p>The peak serum levels measured in animal experiments at arthropathic dosages were far higher than the corresponding concentrations in children.</p><p>However, due to the fact that clinical experience is limited, the use of norfloxacin in children is not recommended.</p><p>In mice and rats, embryotoxicity was not observed, but in rabbits and monkeys, high doses of norfloxacin resulted in increased embryolethality.</p><p>Norfloxacin (at supra-therapeutic doses) can have genotoxic effects in mammalian cells by inhibition of topoisomerases.</p><p>Some fluoroquinolones have weak photomutagenic or phototumorigenic effects in vitro or in animal experiments.</p><p>No other significant teratogenic, mutagenic or carcinogenic effects have been observed.</p><p>During the years of therapeutic use there have been no grounds for suspecting a potential cataractogenic effect following exposure to norfloxacin. No test that could clarify this damaging quality have been performed with norfloxacin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:528px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients: </u></strong></p></td></tr><tr><td style="vertical-align:top"><ol><li>Sodium starch glycolate (Primojel)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Crosscarmellose sodium (Ac-Di-Sol)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Microcrystalline cellulose (Avicel PH 102)</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Polyvinyl pyrrolidone</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Magnesium stearate</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Ethanol Absolute *</li></ol></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Coating Materials:</u></strong></p></td></tr><tr><td style="vertical-align:top"><ol><li>Hypromellose</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Titanium dioxide</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Purified water*</li></ol></td></tr><tr><td style="vertical-align:top"><ol><li>Alcohol (Ethanol 95%)*</li></ol></td></tr></tbody></table><p>&nbsp;</p><p>* Evaporates during manufacturing process and does not appear in the final product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                30 months from the date of manufacturing.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, in a dry place, protected from light</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>14 tablets in a blister strips, packed in a printed carton along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                22. November. 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>